Novo

Novo Nordisk has entered into exclusive negotiations with BIO JAG, BIOCORP’s main shareholder, for the purchase of its entire stake in BIOCORP, representing 45.3% of its share capital and 62.2% of its theoretical voting rights, at a price…

Bagsværd, Denmark, 26 May 2023 – Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending once-weekly Sogroya® (somapacitan)…

Life…

…

…

<!-- Name:DistributionId Value:1000795783 --> <!-- Name:NewsArchiveTags Value:1491,5355 --> <!-- Name:NewsArchiveOrgTags…

<!-- Name:DistributionId Value:1000784124 --> <!-- Name:NewsArchiveTags Value:1491,5356 --> <!-- Name:NewsArchiveOrgTags…

<!-- Name:DistributionId Value:1000781927 --> <!-- Name:NewsArchiveTags Value:1491,5355 --> <!-- Name:NewsArchiveOrgTags…

<!-- Name:DistributionId Value:1000780712 --> <!-- Name:NewsArchiveTags Value:6134 --> <!-- Name:NewsArchiveOrgTags…

<!-- Name:DistributionId Value:1000780106 --> <!-- Name:NewsArchiveTags Value:1491,5356 --> <!-- Name:NewsArchiveOrgTags…